EMILY KRAVINSKY: Open Payments
NPI 1205954138 · JENKINTOWN, PA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$452 in 20 payments from 8 companies in 2025. Trend: 2023 $70 · 2024 $660 · 2025 $452
Food & beverage: $452
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 4 | $100 |
| Vanda Pharmaceuticals Inc. | 3 | $81 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 4 | $79 |
| E.R. Squibb & Sons, L.L.C. | 3 | $72 |
| Teva Pharmaceuticals USA, Inc. | 2 | $38 |
| Otsuka America Pharmaceutical, Inc. | 2 | $35 |
| Janssen Pharmaceuticals, Inc | 1 | $30 |
| Alkermes, Inc. | 1 | $17 |
Products named: FANAPT, CAPLYTA, COBENFY, VRAYLAR, INVEGA SUSTENNA, UZEDY, ABILIFY ASIMTUFII, ARISTADA.
Industry payments across PA — which companies pay providers there.
